Sort
21,453 grants matching “tuberculosis”
Molecular pathogenesis and Blastomyces adherence
$229,500Bruce Steven Klein · University Of Wisconsin-Madison · R21 · FY2016 · AI
CONTACT-MEDIATED HOST RESISTANCE TO M TUBERCULOSIS
$229,500Case Western Reserve University · R01 · FY2000 · HL
M.tuberculosis-induced Alternative Processing of IL12RB1 mRNA
$229,500Richard Robinson · Medical College Of Wisconsin · R21 · FY2013 · AI
CONTACT-MEDIATED HOST RESISTANCE TO M TUBERCULOSIS
$229,500Case Western Reserve University · R01 · FY2001 · HL
Type II-NDHs in M. tuberculosis respiration and persistence
$229,500Thomas C. Zahrt · Medical College Of Wisconsin · R21 · FY2016 · AI
Towards drugs that prevent resistance to the HIV OI, TB
$229,365Univ Of Med/Dent Of Nj-Nj Medical School · R21 · FY2005 · AI
RESEARCH ON BOVINE TUBERCULOSIS: MICHIGAN AND MINNESOTA
$229,343Michigan State University · · FY2009 · National Institute of Food and Agriculture
TB Alliance CETR Administrative Core
$229,293Nader Fotouhi · Global Alliance For Tb Drug Development · U19 · FY2023 · AI
Doctoral Training Program in Tropical Public Health
$229,256Dyann F Wirth · Harvard School Of Public Health · T32 · FY2011 · AI
Sigma factor networks of M. tuberculosis
$229,240Maria Laura Gennaro · Univ Of Med/Dent Of Nj-Nj Medical School · R21 · FY2011 · AI
An Immunomics Approach To Explore Drug-Induced Resistance To Schistosomes
$229,220Rodrigo Correa-Oliveira · Foundation For Research Development · P50 · FY2014 · AI
Protein tyrosine phosphorylation by dual specificity kinases in M. tuberculosis
$229,200Christoph Grundner · Seattle Biomedical Research Institute · R21 · FY2015 · AI
Developmental Core
$229,159Duane T. Smoot · Vanderbilt University Medical Center · P30 · FY2018 · AI
Mobilization of tissue-resident lymphocytes during secondary infection
$229,158Tessa Bergsbaken · Rbhs-New Jersey Medical School · R21 · FY2020 · AI
A New Paradigm for HIV Treatment: Targeted Degradation of HIV Reverse Transcriptase via the Ubiquitin-Proteasome Pathway
$229,049Robert C Reynolds · University Of Alabama At Birmingham · R21 · FY2022 · AI
Study of M. tuberculosis under human host selection to identify virulence and barrier lipids (Project 1)
$228,958David Branch Moody · Brigham And Women'S Hospital · U19 · FY2022 · AI
Molecular confirmation of tuberculosis treatment
$228,926Gerard A Cangelosi · University Of Washington · R21 · FY2019 · AI
ASSIGNING PROTEIN FUNCTIONS FOR PATHOGEN GENOMES
$228,879Protein Pathways, Inc. · R44 · FY2002 · AI
Investigating the impact of helminth infection on microbioma composition and innate immunity generated during HepB vaccination.
$228,809Rafick-Pierre Sekaly · Drexel University · U19 · FY2021 · AI
MODIFYING THE LUNG TO INDUCE STERILE VACCINE-INDUCED PROTECTION AGAINST MTB INFECTION
$228,750Shabaana A. Khader · Washington University · R21 · FY2017 · AI
Targeting Fatty Acid Metabolism to Treat TB
$228,750Jennifer A Philips · Washington University · R21 · FY2017 · AI
Host Pathways that Enable /Salmonella/ Replication Within Hemophagocytic Macropha
$228,750Corrella Detweiler · University Of Colorado · R21 · FY2012 · AI
Enzyme-based lysis of mycobacteria
$228,750Anil Kumar Ojha · University Of Pittsburgh At Pittsburgh · R21 · FY2014 · AI
Examination of phage resistance and susceptibility in M tuberculosis
$228,750Jeffrey D. Cirillo · Texas A&M University Health Science Ctr · R21 · FY2024 · AI
The role of Kainate receptors in oligodendrocyte toxicity and EAE
$228,750Geoffrey T Swanson · Northwestern University At Chicago · R21 · FY2010 · NS